568 related articles for article (PubMed ID: 25420908)
21. Prostate growth and inflammation.
Sciarra A; Mariotti G; Salciccia S; Autran Gomez A; Monti S; Toscano V; Di Silverio F
J Steroid Biochem Mol Biol; 2008 Feb; 108(3-5):254-60. PubMed ID: 17935971
[TBL] [Abstract][Full Text] [Related]
22. Immunohistochemical expression of interleukin-2 receptor and interleukin-6 in patients with prostate cancer and benign prostatic hyperplasia: association with asymptomatic inflammatory prostatitis NIH category IV.
Engelhardt PF; Seklehner S; Brustmann H; Lusuardi L; Riedl CR
Scand J Urol; 2015 Apr; 49(2):120-6. PubMed ID: 25363611
[TBL] [Abstract][Full Text] [Related]
23. Serum Levels of miR-223-3p and miR-223-5p in Prostate Diseases.
Dülgeroğlu Y; Eroğlu O
Microrna; 2020; 9(4):303-309. PubMed ID: 33155933
[TBL] [Abstract][Full Text] [Related]
24. The effect of prostate tissue inflammation in benign prostatic hyperplasia on enhancer of zeste homolog 2 ribonucleic acid expression.
Al-Maghrebi M; Kehinde EO; Al-Mulla F; Anim JT
Ann Saudi Med; 2012; 32(3):262-8. PubMed ID: 22588437
[TBL] [Abstract][Full Text] [Related]
25. [Differences in pathological features of histological inflammation between benign prostatic hyperplasia and prostate cancer].
Yang L; Zhao K; Zhang A; Liu LR; Liu ZH; Han P; Wei Q
Sichuan Da Xue Xue Bao Yi Xue Ban; 2013 Sep; 44(5):760-3, 768. PubMed ID: 24325107
[TBL] [Abstract][Full Text] [Related]
26. Association of prostatic inflammation with down-regulation of macrophage inhibitory cytokine-1 gene in symptomatic benign prostatic hyperplasia.
Taoka R; Tsukuda F; Ishikawa M; Haba R; Kakehi Y
J Urol; 2004 Jun; 171(6 Pt 1):2330-5. PubMed ID: 15126815
[TBL] [Abstract][Full Text] [Related]
27. Evaluation of biomarker canine-prostate specific arginine esterase (CPSE) for the diagnosis of benign prostatic hyperplasia.
Pinheiro D; Machado J; Viegas C; Baptista C; Bastos E; Magalhães J; Pires MA; Cardoso L; Martins-Bessa A
BMC Vet Res; 2017 Mar; 13(1):76. PubMed ID: 28335775
[TBL] [Abstract][Full Text] [Related]
28. Evaluation of serum and seminal plasma markers in the diagnosis of canine prostatic disorders.
Bell FW; Klausner JS; Hayden DW; Lund EM; Liebenstein BB; Feeney DA; Johnston SD; Shivers JL; Ewing CM; Isaacs WB
J Vet Intern Med; 1995; 9(3):149-53. PubMed ID: 7545754
[TBL] [Abstract][Full Text] [Related]
29. Autopsy study of prostatic weight and lesions in LUTH: a 12 month prospective study.
Erinomo OO; Anunobi CC; Orah NO
Nig Q J Hosp Med; 2013; 23(2):85-9. PubMed ID: 24579501
[TBL] [Abstract][Full Text] [Related]
30. The role of chronic prostatic inflammation in the pathogenesis and progression of benign prostatic hyperplasia (BPH).
Gandaglia G; Briganti A; Gontero P; Mondaini N; Novara G; Salonia A; Sciarra A; Montorsi F
BJU Int; 2013 Aug; 112(4):432-41. PubMed ID: 23650937
[TBL] [Abstract][Full Text] [Related]
31. Can expressed prostatic secretions effect prostate biopsy decision of urologist?
Ergun O; Capar E; Goger YE; Ergun AG
Int Braz J Urol; 2019; 45(2):246-252. PubMed ID: 30648827
[TBL] [Abstract][Full Text] [Related]
32. Pharmacological treatment for common prostatic conditions in dogs - benign prostatic hyperplasia and prostatitis: an update.
Niżański W; Levy X; Ochota M; Pasikowska J
Reprod Domest Anim; 2014 Jun; 49 Suppl 2():8-15. PubMed ID: 24947855
[TBL] [Abstract][Full Text] [Related]
33. Benign prostatic hyperplasia and prostate cancer differentiation via platelet to lymphocyte ratio.
Kaynar M; Yildirim ME; Gul M; Kilic O; Ceylan K; Goktas S
Cancer Biomark; 2015; 15(3):317-23. PubMed ID: 25586096
[TBL] [Abstract][Full Text] [Related]
34. Role of inflammation in benign prostatic hyperplasia development among Han Chinese: A population-based and single-institutional analysis.
Hu J; Zhang L; Zou L; Hu M; Fan J; Cai Y; Xu G; Fang J; Ding Q; Jiang H
Int J Urol; 2015 Dec; 22(12):1138-42. PubMed ID: 26311564
[TBL] [Abstract][Full Text] [Related]
35. Pathological patterns of prostate biopsy in men with fluctuations of prostate cancer gene 3 score: a preliminary report.
De Luca S; Passera R; Cappia S; Bollito E; Randone DF; Porpiglia F
Anticancer Res; 2015 Apr; 35(4):2417-22. PubMed ID: 25862908
[TBL] [Abstract][Full Text] [Related]
36. Intraepithelial lymphocytes in relation to NIH category IV prostatitis in autopsy prostate.
Dikov D; Bachurska S; Staikov D; Sarafian V
Prostate; 2015 Jul; 75(10):1074-84. PubMed ID: 25917232
[TBL] [Abstract][Full Text] [Related]
37. The histological prevalence of prostatitis at Potchefstroom Hospital: a cross-sectional study.
Prince Kasongo M; Philippa E; Fabienne WH; Marylyne Y; Behnazir M
Pan Afr Med J; 2024; 47():8. PubMed ID: 38371643
[TBL] [Abstract][Full Text] [Related]
38. Baseline prostate inflammation is associated with a reduced risk of prostate cancer in men undergoing repeat prostate biopsy: results from the REDUCE study.
Moreira DM; Nickel JC; Gerber L; Muller RL; Andriole GL; Castro-Santamaria R; Freedland SJ
Cancer; 2014 Jan; 120(2):190-6. PubMed ID: 24323568
[TBL] [Abstract][Full Text] [Related]
39. Altered expression of p53, but not Rb, is involved in canine prostatic carcinogenesis.
Pagliarone S; Frattone L; Pirocchi V; Della Salda L; Palmieri C
Res Vet Sci; 2016 Apr; 105():195-9. PubMed ID: 27033932
[TBL] [Abstract][Full Text] [Related]
40. Oxidative stress parameters in patients with prostate cancer, benign prostatic hyperplasia and asymptomatic inflammatory prostatitis: A prospective controlled study.
Kaya E; Ozgok Y; Zor M; Eken A; Bedir S; Erdem O; Ebiloglu T; Ergin G
Adv Clin Exp Med; 2017 Oct; 26(7):1095-1099. PubMed ID: 29211357
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]